Latest updates for Nirmatrelvir

Fresh curated links around nirmatrelvir are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • FDA Nod for Merck HIV Drug Brings Competition to a Gilead Sciences Antiretroviral
  • <![CDATA[FDA Approves Idvynso for Treatment of HIV-1 Infection in Adults]]>

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

medcitynews.com /1 month ago

FDA Nod for Merck HIV Drug Brings Competition to a Gilead Sciences Antiretroviral

Merck’s HIV drug Idvynso could become a drug choice for patients who need to switch from Gilead Sciences’ Biktarvy for safety or tolerability reasons. The Merck combination drug pa...

Read source
pharmexec.com /1 month ago

&lt;![CDATA[FDA Approves Idvynso for Treatment of HIV-1 Infection in Adults]]&gt;

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Nirmatrelvir

medcitynews.com

Recent coverage from public sources
Public source

pharmexec.com

Recent coverage from public sources
Public source